JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB171529

450 nm Stop Solution for TMB Substrate

Be the first to review this product! Submit a review

|

(23 Publications)

450 nm Stop Solution for TMB Substrate is a ready to suse stop solution for colorimetric HRP-based ELISA detection.

- Designed to work with our range of TMB substrates
- For colorimetric readout at 450 nm

Key facts

Applications

ELISA

applications

Form

Liquid

form

Storage buffer

pH: 1 - 5 Constituents: 5% Methanesulphonic acid

storage-buffer

style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p>Equal volumes of TMB ELISA Substrate and 450 nm Stop Solution for TMB Substrate should be used.</p>" } } }
style
left-column
style
left-column

Product details

Abcam's 450 nm Stop Solution for TMB Substrate is a ready-to-use solution for colorimetric HRP-based ELISA detection. The acidic formulation is a proprietary solution used to stop TMB ELISA Substrate reactions (ab171522, ab171523, ab171524, ab171525, ab171526 and ab171527) and changes the chromogen from blue (620 nm) to yellow (450 nm) in color.

Product Use:
Equal volumes of TMB ELISA Substrate and 450 nm Stop Solution for TMB Substrate should be used.

style
left-column

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
Ambient
Appropriate long-term storage conditions
Ambient
style
left-column
style
left-column
style
left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

Target data

style
left-column

Publications (23)

Recent publications for all applications. Explore the full list and refine your search

Vaccines 11: PubMed38140233

2023

Preliminary Study on the Efficacy of a Recombinant, Subunit SARS-CoV-2 Animal Vaccine against Virulent SARS-CoV-2 Challenge in Cats.

Applications

Unspecified application

Species

Unspecified reactive species

Igor Morozov,Natasha N Gaudreault,Jessie D Trujillo,Sabarish V Indran,Konner Cool,Taeyong Kwon,David A Meekins,Velmurugan Balaraman,Bianca Libanori Artiaga,Daniel W Madden,Chester McDowell,Bradley Njaa,Jamie Retallick,Nicole Hainer,Jason Millership,William C Wilson,George Tkalcevic,Hanne Vander Horst,Yulia Burakova,Vickie King,Kendra Hutchinson,John M Hardham,Denise J Schwahn,Mahesh Kumar,Juergen A Richt

PloS one 18:e0287047 PubMed37315033

2023

Evaluation of 18F labeled glial fibrillary acidic protein binding nanobody and its brain shuttle peptide fusion proteins using a neuroinflammation rat model.

Applications

Unspecified application

Species

Unspecified reactive species

Takahiro Morito,Ryuichi Harada,Ren Iwata,Yoichi Ishikawa,Nobuyuki Okamura,Yukitsuka Kudo,Shozo Furumoto,Kazuhiko Yanai,Manabu Tashiro

NPJ vaccines 8:31 PubMed36871059

2023

Immunogenicity and protective activity of mRNA vaccine candidates against yellow fever virus in animal models.

Applications

Unspecified application

Species

Unspecified reactive species

Lex G Medina-Magües,Janine Mühe,Edith Jasny,Emily S Medina-Magües,Nicole Roth,Jaime Lopera-Madrid,Cristhian Salas-Quinchucua,Cole Knuese,Benjamin Petsch,Jorge E Osorio

Biomaterials 292:121907 PubMed36436305

2022

Respiratory mucosal vaccination of peptide-poloxamine-DNA nanoparticles provides complete protection against lethal SARS-CoV-2 challenge.

Applications

Unspecified application

Species

Unspecified reactive species

Si Sun,Entao Li,Gan Zhao,Jie Tang,Qianfei Zuo,Larry Cai,Chuanfei Xu,Cheng Sui,Yangxue Ou,Chang Liu,Haibo Li,Yuan Ding,Chao Li,Dongshui Lu,Weijun Zhang,Ping Luo,Ping Cheng,Yuwei Gao,Changchun Tu,Bruno Pitard,Joseph Rosenecker,Bin Wang,Yan Liu,Quanming Zou,Shan Guan

Viruses 14: PubMed36146773

2022

SARS-CoV-2 Spike and Nucleocapsid Antibody Response in Vaccinated Croatian Healthcare Workers and Infected Hospitalized Patients: A Single Center Cohort Study.

Applications

Unspecified application

Species

Unspecified reactive species

Paola Kučan Brlić,Martina Pavletić,Mate Lerga,Fran Krstanović,Marina Pribanić Matešić,Karmela Miklić,Suzana Malić,Leonarda Mikša,Maja Pajcur,Dolores Peruč,Maren Schubert,Federico Bertoglio,Jurica Arapović,Alen Protić,Alan Šustić,Marko Milošević,Luka Čičin Šain,Stipan Jonjić,Vanda Juranić Lisnić,Ilija Brizić

Proceedings of the National Academy of Sciences of the United States of America 119:e2123362119 PubMed35921433

2022

Gammaherpesvirus-mediated repression reveals EWSR1 to be a negative regulator of B cell responses.

Applications

Unspecified application

Species

Unspecified reactive species

Yiping Wang,April Feswick,Vasiliki Apostolou,Petko M Petkov,Emily K Moser,Scott A Tibbetts

Frontiers in veterinary science 9:864884 PubMed35754530

2022

Development of an Indirect ELISA for the Detection of SARS-CoV-2 Antibodies in Cats.

Applications

Unspecified application

Species

Unspecified reactive species

Dashzeveg Bold,Gleyder Roman-Sosa,Natasha N Gaudreault,Batsukh Zayat,Roman M Pogranichniy,Juergen A Richt

Frontiers in immunology 13:879157 PubMed35619694

2022

Insights Into Immunothrombotic Mechanisms in Acute Stroke due to Vaccine-Induced Immune Thrombotic Thrombocytopenia.

Applications

Unspecified application

Species

Unspecified reactive species

Nicole de Buhr,Tristan Baumann,Christopher Werlein,Leonie Fingerhut,Rabea Imker,Marita Meurer,Friedrich Götz,Paul Bronzlik,Mark P Kühnel,Danny D Jonigk,Johanna Ernst,Andrei Leotescu,Maria M Gabriel,Hans Worthmann,Ralf Lichtinghagen,Andreas Tiede,Maren von Köckritz-Blickwede,Christine S Falk,Karin Weissenborn,Ramona Schuppner,Gerrit M Grosse

Frontiers in immunology 13:833418 PubMed35356002

2022

Novel Synthetic Lipopeptides as Potential Mucosal Adjuvants Enhanced SARS-CoV-2 rRBD-Induced Immune Response.

Applications

Unspecified application

Species

Unspecified reactive species

Ling Mao,Chang Liu,Jing-Yi Liu,Zi-Li Jin,Zhe Jin,Ruo-Yi Xue,Rang Feng,Guo-Cheng Li,Yan Deng,Hao Cheng,Quan-Ming Zou,Hai-Bo Li

Communications biology 5:157 PubMed35197550

2022

Fortilin interacts with TGF-β1 and prevents TGF-β receptor activation.

Applications

Unspecified application

Species

Unspecified reactive species

Decha Pinkaew,Erik Martinez-Hackert,Wei Jia,Matthew D King,Fei Miao,Nicole R Enger,Runglawan Silakit,Kota Ramana,Shi-You Chen,Ken Fujise
View all publications
style
left-column
style
left-column

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
style
left-column
style
right-column

Associated Products

Select an associated product type
Alternative Product
Reagents, Controls & Accessories

AB171531

650 nm Stop Solution for TMB Substrate

reagents

650-nm-stop-solution-for-tmb-substrate-ab171531

0

(0 reviews)

style
bg-slate-100

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com